Active — Not RecruitingNot Applicable

Paravertebral Calcitonin in Thoracotomy

Egypt92 participantsStarted 2024-03-28

Plain-language summary

This prospective randomized double-blinded controlled study will be conducted to evaluate the effect of adding calcitonin to bupivacaine in thoracic paravertebral block for patients undergoing thoracotomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged ≥ 18 years * American society of anesthesiology (ASA) physical status of I-III * scheduled for elective thoracotomy Exclusion Criteria: * Contraindication to thoracic paravertebral block as coagulopathy or local anesthetic allergy. * Pregnancy * History of cardiovascular and gastro-esophageal surgery * Preexisting pain syndrome or psychological disorders * Severe hepatic, cardiovascular, or renal disorders * Allergy to calcitonin * Patients who will be re-operated and who will report infections

What they're measuring

morphine consumption

Timeframe: from the end of surgery until the end of the first postoperative day

Incidence of chronic pain at 3 months after surgery

Timeframe: 3 months after surgery

Trial details

NCT IDNCT06330168

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-14

View on ClinicalTrials.gov More Calcitonin trials